BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24065476)

  • 1. AKAP12/Gravin gene expression in colorectal cancer: clinical importance and review of the literature.
    Yildirim M; Suren D; Yildiz M; Sezgin Alikanoglu A; Eryilmaz R; Goktas S; Bulbuller N; Sezer C
    J BUON; 2013; 18(3):635-40. PubMed ID: 24065476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of AKAP12 with HDAC3 depletion suppresses the progression and migration of colorectal cancer.
    He P; Li K; Li SB; Hu TT; Guan M; Sun FY; Liu WW
    Int J Oncol; 2018 Apr; 52(4):1305-1316. PubMed ID: 29484387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
    Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y
    J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-expression of AKAP12 inhibits progression and metastasis potential of colorectal carcinoma in vivo and in vitro.
    Liu W; Guan M; Hu T; Gu X; Lu Y
    PLoS One; 2011; 6(8):e24015. PubMed ID: 21918680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
    Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
    J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasohibin-1 increases the malignant potential of colorectal cancer and is a biomarker of poor prognosis.
    Kitajima T; Toiyama Y; Tanaka K; Saigusa S; Kobayashi M; Inoue Y; Mohri Y; Kusunoki M
    Anticancer Res; 2014 Oct; 34(10):5321-9. PubMed ID: 25275025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
    Karamitopoulou E; Zlobec I; Panayiotides I; Patsouris ES; Peros G; Rallis G; Lapas C; Karakitsos P; Terracciano LM; Lugli A
    Hum Pathol; 2011 Dec; 42(12):1888-96. PubMed ID: 21664646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of relation of AKAP12 with p53 and Bcl-2 in colorectal carcinoma.
    Suren D; Yildirim M; Alikanoglu AS; Kaya V; Yildiz M; Dilli UD; Sezer C
    Asian Pac J Cancer Prev; 2014; 15(8):3415-8. PubMed ID: 24870731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid determination of AKAP12 promoter methylation levels in peripheral blood using methylation-sensitive high resolution melting (MS-HRM) analysis: application in colorectal cancer.
    Liu W; Guan M; Su B; Li J; Ma W; Liu C; Li M; Lin Y; Lu Y
    Clin Chim Acta; 2010 Jul; 411(13-14):940-6. PubMed ID: 20227403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
    Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J
    Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of secretory leukocyte protease inhibitor detected by immunohistochemistry correlating with prognosis and metastasis in colorectal cancer.
    Liu G; Yang J; Zhao Y; Wang Z; Xing B; Wang L; Shi D
    World J Surg Oncol; 2014 Dec; 12():369. PubMed ID: 25441765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
    Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of endothelial cell migration through the down‑regulation of MMP-9 by A-kinase anchoring protein 12.
    Lee SW; Jung KH; Jeong CH; Seo JH; Yoon DK; Suh JK; Kim KW; Kim WJ
    Mol Med Rep; 2011; 4(1):145-9. PubMed ID: 21461577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of HDAC1 and CBP/p300 in human colorectal carcinomas.
    Ishihama K; Yamakawa M; Semba S; Takeda H; Kawata S; Kimura S; Kimura W
    J Clin Pathol; 2007 Nov; 60(11):1205-10. PubMed ID: 17720775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
    Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH
    Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch2 expression is decreased in colorectal cancer and related to tumor differentiation status.
    Chu D; Zheng J; Wang W; Zhao Q; Li Y; Li J; Xie H; Zhang H; Dong G; Xu C; Li M; Chen D; Ji G
    Ann Surg Oncol; 2009 Dec; 16(12):3259-66. PubMed ID: 19653042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
    Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M
    Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67.
    Hanna-Morris A; Badvie S; Cohen P; McCullough T; Andreyev HJ; Allen-Mersh TG
    J Clin Pathol; 2009 Apr; 62(4):325-30. PubMed ID: 18474544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.